Simulations Plus, Inc. (NASDAQ:SLP) Given Consensus Rating of “Buy” by Brokerages

Shares of Simulations Plus, Inc. (NASDAQ:SLP) have earned a consensus rating of “Buy” from the seven analysts that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $51.40.

A number of equities research analysts have recently commented on SLP shares. StockNews.com cut shares of Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, November 4th. KeyCorp began coverage on shares of Simulations Plus in a report on Monday, July 29th. They set an “overweight” rating and a $47.00 price target for the company. BTIG Research cut their price target on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a report on Thursday, October 24th. William Blair reissued an “outperform” rating on shares of Simulations Plus in a report on Wednesday, November 6th. Finally, Stephens initiated coverage on shares of Simulations Plus in a report on Friday. They issued an “overweight” rating and a $39.00 target price for the company.

Insiders Place Their Bets

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction that occurred on Friday, November 1st. The shares were sold at an average price of $27.66, for a total transaction of $553,200.00. Following the transaction, the director now owns 3,462,584 shares of the company’s stock, valued at $95,775,073.44. This trade represents a 0.57 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders have sold a total of 60,750 shares of company stock valued at $1,905,655 over the last quarter. Company insiders own 20.90% of the company’s stock.

Hedge Funds Weigh In On Simulations Plus

Hedge funds have recently made changes to their positions in the business. First Horizon Advisors Inc. increased its stake in Simulations Plus by 82.6% during the 3rd quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company’s stock worth $26,000 after buying an additional 370 shares during the period. nVerses Capital LLC increased its stake in Simulations Plus by 1,100.0% during the 3rd quarter. nVerses Capital LLC now owns 1,200 shares of the technology company’s stock worth $38,000 after buying an additional 1,100 shares during the period. EntryPoint Capital LLC purchased a new stake in Simulations Plus during the 1st quarter worth $57,000. Quantbot Technologies LP purchased a new stake in Simulations Plus during the 3rd quarter worth $59,000. Finally, Allspring Global Investments Holdings LLC purchased a new stake in Simulations Plus during the 1st quarter worth $70,000. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Simulations Plus Stock Down 3.2 %

NASDAQ:SLP opened at $28.77 on Monday. The company has a fifty day simple moving average of $31.19 and a two-hundred day simple moving average of $38.88. The company has a market cap of $577.41 million, a price-to-earnings ratio of 58.72 and a beta of 0.71. Simulations Plus has a 52 week low of $27.22 and a 52 week high of $51.22.

Simulations Plus (NASDAQ:SLP) last released its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.02. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The company had revenue of $18.70 million during the quarter, compared to the consensus estimate of $19.73 million. During the same quarter in the prior year, the firm posted $0.18 earnings per share. Simulations Plus’s revenue for the quarter was up 19.9% on a year-over-year basis. On average, analysts expect that Simulations Plus will post 1.12 EPS for the current year.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.